Although herpes simplex virus type 1 (HSV-1) does not induce apoptosis in infected HEp-2 cells, in the presence of cycloheximide infection induced apoptosis with characteristic morphological changes as well as endonucleosomal DNA cleavage. The induction of apoptosis without de novo protein synthesis suggests that a structural protein of the HSV-1 virion is responsible for the observed apoptosis.
Apoptosis or programmed cell death (PCD) is a type of animal cell death in which cells die by an active cellular process under the control of a genetically encoded cell suicide programme. Apoptosis is characterized morphologically by cell shrinkage, plasma-membrane blebbing, chromatin condensation and nuclear fragmentation and biochemically by degradation of chromosomal DNA into oligonucleosomesized fragments (Kerr & Harmon, 1991) . Although many animal viruses are known to induce an apoptotic response in infected cells (Clem & Miller, 1994 ; Shen & Shenk, 1995 ; White & Gooding, 1994) , cells infected with wild-type herpes simplex virus type 1 (HSV-1) do not show apoptotic characteristics. However, based on the finding that mutant virus which lacks the γ34.5 gene induces PCD in infected human cells (Chou & Roizman, 1992 ; Chou et al., 1994) , the lack of apoptosis in the HSV-1-infected cells has been considered to be an outcome of expression of a viral antiapoptosis gene whose product inhibits one of the steps in the virus-induced signalling leading to PCD. Later, HSV-1 was found to carry, as well as the γ34.5 gene, an antiapoptosis gene which can suppress the cellular apoptotic response induced by hyperthermia (Leopardi & Roizman, 1996) or sorbitol treatment (Koyama & Miwa, 1997 HEp-2 cells were grown in minimal essential medium with Earle's salts (MEM) supplemented with 10 % new-born bovine serum. HSV-1 strain HF was used in all experiments. Virus infection was carried out by essentially the same procedure as described previously (Koyama & Uchida, 1994) .
Methods to determine the degree of DNA fragmentation or to examine nuclear morphology have been described previously (Koyama, 1995 ; Koyama & Miwa, 1997) . Briefly, monolayered cells were harvested with trypsin, and fragmented DNA was extracted from the cells by the method of Hirt (1967) with minor modifications and analysed for oligonucleosomal DNA ladders by electrophoresis on a 1n5% agarose gel. For quantification of the chromosomal DNA extracted in the fragmented DNA fraction, cellular DNA was labelled with [$H]thymidine prior to infection and the radioactivity in fractions of total and extracted DNA was determined. Fig. 1 shows a one-step growth curve of HSV-1 and endonucleosomal DNA-cleavage patterns in infected HEp-2 cells. Progeny virus appeared at 6 h post-infection (p.i.), increased with time and reached a maximum level at about 12 h p.i. However, at no stage of infection could fragmentation of chromosomal DNA into nucleosomal oligomers be detected, consistent with the previous observation that virus-induced apoptosis is not found in HSV-1-infected HEp-2 cells (Koyama & Miwa, 1997) .
In agreement with this lack of DNA fragmentation, the morphology of HSV-1-infected cell nuclei showed no changes characteristic of apoptosis. The morphology of the infected cell nuclei at 27 h p.i. (Fig. 2 b) was significantly different from that in uninfected cells (Fig. 2 a) , but neither chromatin condensation nor nuclear fragmentation was observed. However, Fig. 2 also shows that in the presence of cycloheximide, an inhibitor of protein synthesis, HSV-1-infected cells showed the characteristic nuclear morphology of apoptotic cells ( Fig. 2 c) ; most of the infected cells showed intense perinuclear chromatin condensation and some of them showed nuclear fragmentation at 27 h p.i. Addition of cycloheximide without infection also induced apoptosis in HEp-2 cells but in a limited number of cells (Fig. 2 d) and with different kinetics ; without infection, apoptotic cells appeared as early as 2 h after incubation with cycloheximide, and the number of apoptotic cells did not increase thereafter.
In agreement with the changes in nuclear morphology, infection in the presence of cycloheximide induced a very strong cytopathic effect (CPE) in the infected cells (data not shown). HSV-1 infection itself did not induce extensive CPE in HEp-2 cells when compared with untreated cells ; even at 24 h p.i., the majority of infected cells remained attached to the dish surface with no obvious morphological changes, although The radioactivity in the total and fragmented DNA fractions was determined separately as described previously (Koyama & Miwa, 1997) .
the nuclear mass of the cells was slightly enlarged and a limited number of small syncytia with two to four nuclei were occasionally observed. In contrast, in the presence of cycloheximide, HSV-1 infection caused severe CPE ; most cells shrank and began to detach from the dish surface, and some had remarkable plasma-membrane blebbing. Incubation of cells with cycloheximide alone for the same period did not result in noticeable CPE, although the number of detaching cells increased significantly.
To further confirm the induction of apoptosis by HSV-1 infection, we examined the classical degradation of chromosomal DNA into nucleosomal oligomers in the HSV-1-infected and uninfected cells in the presence of cycloheximide (Fig. 3) . In the infected cells, oligonucleosomal DNA ladders were clearly visible after 11 h p.i. but were not visible in uninfected cells (Fig. 3 a) , demonstrating that, in the presence of cycloheximide, HSV-1 infection induces apoptosis. The DNA ladder became less clear at 24 h p.i. although the amount of fragmented DNA apparently increased with time, probably because of non-specific nucleolysis of fragmented DNA molecules. Fig. 3 (b) shows the kinetics of the increase in the amount of fragmented DNA in these cells. Although we usually found a significant amount of fragmented DNA in extract from untreated HEp-2 cells (Koyama & Miwa, 1997) , infection with HSV-1 in the absence of cycloheximide did not result in any increase in the amount of fragmented DNA. On the other hand, when cells were mock-infected and incubated with cycloheximide, significant fragmentation of chromosomal DNA occurred in the first 2 h of the incubation but with no subsequent progression. In addition, although the ladder was not visible in uninfected samples (Fig. 3 a) , it could be observed, in some experiments, at 2 h post-treatment. These results are in good agreement with the morphological studies (Fig. 2 d) and indicate that a small fraction of HEp-2 cells is sensitive to cycloheximide and undergoes apoptosis induced by this reagent. In contrast, infection with HSV-1 in the presence of cycloheximide induces extensive fragmentation of chromosomal DNA, but with very slow kinetics. Fragmentation started with kinetics similar to that in cycloheximide-treated uninfected cells, but the amount of fragmented DNA increased continuously with time and reached a plateau at about 24 h p.i. The slow kinetics might explain the incomplete level of apoptosis reported by LaCount & Friesen (1997) . They reported that, although the induction of maximum apoptosis requires normal viral DNA synthesis or late gene expression, baculovirus-induced apoptosis can be triggered by an early event (pre-DNA synthesis) in the absence of normal virus replication.
The results shown here demonstrate that wild-type HSV-1 can induce apoptosis when infection occurs in the presence of cycloheximide. The induction of apoptosis in the presence of cycloheximide indicates that de novo synthesis of both viral and cellular proteins is not required. To rule out the possibility of residual virus gene expression being responsible for apoptosis in cycloheximide-treated cells, we (1) pretreated cells with the reagent for 30 min prior to virus infection or (2) used UVinactivated virus (approximately 1\100 of the infectivity after UV irradiation) instead of normal unirradiated virus. The results of these experiments were essentially the same as those described above (not shown). In addition, the possibility that HSV-1 infection is merely potentiating the effect of cycloheximide is less likely, because (1) incubation of HEp-2 cells with the reagent at higher concentrations (up to 100 µg\ml) did not affect the degree of apoptosis in treated cultures (data not shown) and (2) the kinetics of DNA fragmentation in cells treated with cycloheximide alone is quite different from the kinetics in HSV-1-infected cells (Fig. 3 b) .
It should be noted that the HSV-1 virion carries several virion-associated enzymes and regulatory proteins (Roizman & Sears, 1996) . Even in the absence of de novo synthesis of viral proteins, some of these enzymes or proteins are able to, and are likely to, interact with cellular components in signalling pathways to induce apoptosis. In this regard, it is noteworthy that C. M. Preston and colleagues reported that HSV-1 carrying a mutation in the coding sequences for the virion transactivator protein VP16 does not show cytotoxicity and can establish latency in infected cells (Harris & Preston, 1991 ; Jamieson et al., 1995 ; Preston et al., 1997) .
Previously, we and others have shown that HSV-1 carries at least two different types of antiapoptosis genes which can inhibit the induction of PCD in infected cells (Chou & Roizman, 1992 ; Chou et al., 1994 ; Koyama & Miwa, 1997 ; Leopardi & Roizman, 1996) . Although we do not know how antiapoptosis gene products can interact with the signalling pathway that leads to virus-induced apoptosis, the role of cycloheximide in our experiments is probably to inhibit the expression of these antiapoptosis genes.
